Sight Sciences, Inc. (SGHT)
NASDAQ: SGHT · Real-Time Price · USD
8.55
+0.14 (1.66%)
Aug 28, 2026, 4:00 PM EDT - Market closed
Sight Sciences Revenue
Sight Sciences had revenue of $23.39M in the quarter ending June 30, 2026, with 19.55% growth. This brings the company's revenue in the last twelve months to $83.38M, up 9.27% year-over-year. In the year 2025, Sight Sciences had annual revenue of $77.36M, down -3.13%.
Revenue (ttm)
$83.38M
Revenue Growth
+9.27%
P/S Ratio
5.65
Revenue / Employee
$448,263
Employees
186
Market Cap
471.00M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 77.36M | -2.50M | -3.13% |
| Dec 31, 2024 | 79.87M | -1.19M | -1.47% |
| Dec 31, 2023 | 81.06M | 9.73M | 13.63% |
| Dec 31, 2022 | 71.33M | 22.38M | 45.70% |
| Dec 31, 2021 | 48.96M | 21.32M | 77.12% |
| Dec 31, 2020 | 27.64M | 4.29M | 18.38% |
| Dec 31, 2019 | 23.35M | 15.82M | 210.07% |
| Dec 31, 2018 | 7.53M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Orthofix Medical | 833.19M |
| Tactile Systems Technology | 350.31M |
| Cerus | 221.55M |
| Pacific Biosciences of California | 159.27M |
| NeuroPace | 106.99M |
| Delcath Systems | 95.42M |
| 908 Devices | 60.84M |
| BrainsWay | 60.70M |
SGHT News
- 11 days ago - Sight Sciences announces updated TearCare System Indications for Use - TheFly
- 12 days ago - TearCare Becomes the First and Only MGD Treatment Indicated to Improve Meibomian Gland Function in Patients with Evaporative Dry Eye Disease - GlobeNewsWire
- 14 days ago - Sight Sciences price target raised to $8 from $6 at Citi - TheFly
- 24 days ago - Sight Sciences price target raised to $8 from $7 at UBS - TheFly
- 25 days ago - Sight Sciences reports Q2 EPS (8c), consensus (14c) - TheFly
- 25 days ago - Sight Sciences raises FY26 revenue view to $88M-$92M from $83M-$89M - TheFly
- 25 days ago - Sight Sciences Earnings Call Transcript: Q2 2026 - Transcripts
- 25 days ago - Sight Sciences Earnings release: Q2 2026 - Filings